TY  - GEN
AU  - Kellerer,M
AU  - Jakob,S
AU  - Linn,T
AU  - Haslbeck,M
TI  - [Continuation 50. Type 2 diabetes: possibilities and limitations of pharmacological therapy]
SN  - 1438-3276
PY  - 2004///0427
KW  - 1-Deoxynojirimycin
KW  - analogs & derivatives
KW  - Acarbose
KW  - administration & dosage
KW  - Aged
KW  - Blood Glucose
KW  - analysis
KW  - Carbamates
KW  - Contraindications
KW  - Cyclohexanes
KW  - Diabetes Mellitus, Type 2
KW  - blood
KW  - Drug Therapy, Combination
KW  - Enzyme Inhibitors
KW  - Fasting
KW  - Follow-Up Studies
KW  - Germany
KW  - epidemiology
KW  - Glucosamine
KW  - Glyburide
KW  - Glycated Hemoglobin
KW  - Glycoside Hydrolase Inhibitors
KW  - Humans
KW  - Hypoglycemia
KW  - chemically induced
KW  - Hypoglycemic Agents
KW  - Imino Pyranoses
KW  - Insulin
KW  - Metformin
KW  - Middle Aged
KW  - Nateglinide
KW  - Obesity
KW  - complications
KW  - Patient Compliance
KW  - Phenylalanine
KW  - Pioglitazone
KW  - Piperidines
KW  - Practice Guidelines as Topic
KW  - Risk Factors
KW  - Rosiglitazone
KW  - Sulfonylurea Compounds
KW  - Thiazolidinediones
KW  - Time Factors
N1  - Publication Type: Comparative Study; Journal Article; Review
ER  -